- Academy of Finland (starting Fall 2020): Human exposure to per- and poly-fluoroalkyl substances – role of the gut microbiome and bile acid metabolism in mediating impact (PFASgut) – PI (Oresic)
- COST action CA19105, Horizon 2020 Programme (starting Fall 2020). LipidNET- Pan-European Network in Lipidomics and Epilipidomics. Working Group leader (Oresic), Clinical significance and applications of (epi)lipidomics
- Academy of Finland (Postdoctoral Research project): Metabolomics meet gut microbiome. A stepping stone towards type 1 diabetes prediction and prevention – PI (Lamichhane)
- Strategic Research Agreement, Juvenile Diabetes Research Foundation: Metabolomic and Proteomic markers staging progression to type 1 diabetes in autoantibody positive children – PI (Oresic)
- Strategic Research Agreement, Juvenile Diabetes Research Foundation: Mother-infant interactions in relation to potential biomarkers of beta-cell autoimmunity and type 1 diabetes – PI (Oresic)
- Awards in Endocrinology & Metabolism, Novo Nordisk Foundation: Lipid pathways en route to islet autoimmunity and type 1 diabetes – PI (Oresic)
- Vetenskapsrådet: Blood-based metabolomics to predict severity and patient outcomes in traumatic brain injury – PI (Oresic)
- Collaborative project, EU Horizon 2020 Innovative Medicines Initiative: Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS) – Metabolomics Task Force leader (Oresic)
We are using cookies to give you a satisfying experience on our site.OkCookie policy 
